Portrait of Jill N. Burke, CNP, DipACLM

Jill N. Burke,

CNP, DipACLM

Jill N. Burke,

CNP, DipACLM

Nurse Practitioner, Massachusetts General Hospital

Portrait of Jill N. Burke, CNP, DipACLM

Jill N. Burke,

CNP, DipACLM

Nurse Practitioner, Massachusetts General Hospital

Jill Burke has spent the last 35 years at Massachusetts General Hospital, with the first 12 years as inpatient hematology/oncology staff nurse, and the last 23 years at a nurse practitioner. Jill’s focus of care has been multiple myeloma for 15 years. She presently works in the outpatient setting, managing patients with plasma cell diseases throughout diagnosis and treatment.

She is a strong patient advocate, ensuring that patients reach their optimal level of functioning and enjoy life. She is known for explaining to newly diagnosed patients that she hopes their diagnosis will occupy a small sliver in the pie of their life. Jill is certified by the American College of Lifestyle Medicine as a lifestyle coach, and she is in the process of organizing lifestyle medicine clinics for patients diagnosed with monoclonal gammopathy of unknown significance, multiple myeloma, and post CAR-T. Jill has given talks and presented posters both nationally and internationally.

Jill's Shared Resources

Daratumumab: Durable Efficacy in Heavily Treated Multiple Myeloma

Daratumumab monotherapy demonstrated promising efficacy and a manageable safety profile in heavily pretreated patients with multiple myeloma in a pooled, post-hoc analysis of the GEN501 and SIRIUS studies. The combined...
CURATED BY:
Jill N. Burke,
CNP, DipACLM

Systemic Light-Chain Amyloidosis and Multiple Myeloma: Overlap, Outcomes, and the Need for Early Diagnosis

Monoclonal gammopathies (MGs), including systemic light-chain (AL) amyloidosis and multiple myeloma (MM), often overlap clinically....
CURATED BY:
Jill N. Burke,
CNP, DipACLM

Next-Generation Sequencing Outperforms ASO-PCR in Detecting MRD and Improving Myeloma Outcomes

Minimal residual disease (MRD) is a key driver of multiple myeloma (MM) relapse, requiring highly sensitive detection methods. Researchers of a retrospective study of 125 patients with MM undergoing autologous...
CURATED BY:
Jill N. Burke,
CNP, DipACLM

Provided by an unrestricted grant from

Provided by an unrestricted grant from

Share